Clare Hodges

Photo: Lajmmoore — CC BY-SA 4.0Source

Clare Hodges

activist

Born
July 6, 1957
Died
August 23, 2011
Age
54 years
Cause
multiple sclerosis

Remembering Clare Hodges: related finds and keepsakes

About Clare Hodges

Clare Hodges, 54, British campaigner for the medical use of cannabis, multiple sclerosis.

Explore other notable deaths in 2011 or deaths in August 2011.

The Deaths Archive presents

How well do you know Clare Hodges?

Explore their life. Test your knowledge. Beat the challenge.

10 questions · One legacy · How much do you really know?

Challenge your friends

Play together in real-time.

Advertisement

Full Biography

|

Clare Hodges (6 July 1957 – 23 August 2011), also known as Elizabeth Brice, was an English activist who advanced the medical understanding of cannabis and campaigned for its widespread benefit as a therapeutic medicine in the United Kingdom. Clare Hodges is the pseudonym that Elizabeth Brice used, Clare being her middle name and Hodges her mother's maiden name.[citation needed]

She was diagnosed with multiple sclerosis (MS) at age 26 but it was nearly 10 years before she tried cannabis to alleviate the symptoms. Hodges found that cannabis greatly alleviated her condition. It was this that motivated her to become an avid cannabis rights campaigner.[citation needed]

Consequently, Hodges founded the Alliance for Cannabis Therapeutics (ACT) in 1992 with two other patients. The ACT worked to provide advice and assistance to other individuals with MS or other medical conditions which might benefit from the use of cannabis.[citation needed]

Hodges took the matter to the House of Lords in 1998 where she spoke about the benefits she had found from the therapeutic use of this illicit drug. She stated "Cannabis helps my body relax. I function and move much easier. The physical effects are very clear. It is not just a vague feeling of well-being".

Despite the backing of several members of the House of Lords, and Austin Mitchell MP, the ACT was unable to change the law in the UK with regard to the use of cannabis. Hodges later went on to join the board of directors of the International Association for Cannabinoid Medicines (IACM) as a patient representative from 2001 until her death in 2011.

Nonetheless, Hodges worked with Dr William Notcutt to ensure GW Pharmaceuticals took up the issue and as a result Sativex is now available as an alternative.

She also addressed the European Parliament in Brussels following which the law was changed in Belgium.

Due to deteriorating health as a result of her MS, Hodges handed over the articles and patient transcripts to the Wellcome Trust in 2009.[citation needed]

On 17 April 2024, a blue plaque was unveiled in Chapel Allerton, commemorating the lives of both Hodges and her husband.

Personal life

Hodges was born in Manchester. She studied Latin and Greek at Somerville College, Oxford. She then went on to pursue a career in medical journalism, first writing for a newspaper for doctors before becoming a producer at Yorkshire Television working on a number of medical documentaries, including several with Dr Miriam Stoppard.[citation needed]

Hodges was married to Duncan Dallas, founder of Café Scientifique, and has two sons.[citation needed]

Content from Wikipedia — licensed under CC BY-SA 3.0

Interactive

Test Your Knowledge – Trivia Challenge

How well do you know this person's life and legacy?

No account needed to play. Sign in to keep your score on the leaderboard.

Books & Media

Find books, audiobooks and films about Clare Hodges on Amazon.

Available at Amazon

As an Amazon Associate I earn from qualifying purchases.

Amazon and the Amazon logo are trademarks of Amazon.com, Inc. or its affiliates.

Sources

People who died on August 23

Related People

Spotted an error?

Help us keep the archive accurate. Report a correction with a source.

Report an error for Clare Hodges →

Advertisement

We use cookies for analytics (Google Analytics 4 and PostHog) and advertising (Google AdSense) to understand site usage and improve your experience. By clicking "Accept All", you consent to the use of these cookies. See our Cookie Policy and Privacy Policy for details.